#1 Clinical Trials Search in Europe

Cefuroxime Sodium

Cefuroxime Sodium is an antibiotic medication being studied in various clinical trials to evaluate its effectiveness in preventing and treating infections. These trials are examining different dosing strategies, administration methods, and patient populations to optimize the use of cefuroxime and improve patient outcomes. The research spans areas such as surgical prophylaxis, treatment of infections during pregnancy, and use in infants and children.

Table of Contents

What is Cefuroxime?

Cefuroxime sodium is an antibiotic medication used to treat various bacterial infections. It belongs to a class of drugs called cephalosporins, which work by killing bacteria or preventing their growth[1]. Cefuroxime is also known by other names, including:

  • Ceftin
  • Cefuroxime “Fresenius Kabi”
These alternative names may be used in different countries or by different manufacturers[2][3].

Uses of Cefuroxime

Cefuroxime is prescribed to treat a variety of bacterial infections, including:

  • Urinary tract infections (UTIs): Including those that occur during pregnancy[1]
  • Pyelonephritis: A serious kidney infection that can occur during pregnancy[4]
  • Surgical site infections: To prevent infections after various surgeries, including cesarean sections and colorectal surgeries[2][5]
  • Respiratory infections: Such as pneumonia in infants and children[6]
It’s important to note that cefuroxime is effective against many types of bacteria, but it doesn’t work for viral infections like the common cold or flu.

How Cefuroxime is Administered

Cefuroxime can be given in several ways, depending on the specific condition being treated and the patient’s age:

  • Intravenous (IV) injection: Directly into a vein, often used in hospital settings[1][5]
  • Oral tablets: Taken by mouth, usually for less severe infections or after initial IV treatment[4]
  • Continuous infusion: A method being studied where the drug is given continuously over a period of time[5]
The method of administration will be determined by your healthcare provider based on your specific condition and needs.

Dosage Information

The dosage of cefuroxime varies depending on several factors, including:

  • The type and severity of the infection
  • The patient’s age and weight
  • Kidney function
  • Other medical conditions
For example, in adults, common dosages range from 750 mg to 1.5 g given every 8 hours for intravenous administration[1][5]. For oral administration, dosages may be around 500 mg every 12 hours[4]. However, it’s crucial to follow your doctor’s specific instructions, as they will determine the right dosage for your individual case.

Effectiveness and Safety

Cefuroxime has been shown to be effective in treating various bacterial infections. Research is ongoing to determine its optimal use in different situations. For instance:

  • Studies are comparing the effectiveness of oral versus intravenous cefuroxime in treating pyelonephritis during pregnancy[4]
  • Research is being conducted on the best timing of cefuroxime administration before surgery to prevent infections[2][5]
  • The safety and effectiveness of cefuroxime in newborns and infants are being studied[6]
These ongoing studies aim to improve our understanding of how to use cefuroxime most effectively and safely in different patient groups.

Potential Side Effects

Like all medications, cefuroxime can cause side effects, although not everyone experiences them. Common side effects may include:

  • Nausea or vomiting
  • Diarrhea
  • Stomach pain
  • Headache
  • Skin rash
In rare cases, more serious side effects can occur. It’s important to inform your healthcare provider if you experience any unusual symptoms while taking cefuroxime[1][4].

Use in Special Populations

Cefuroxime is used in various patient groups, but special considerations may apply:

  • Pregnant women: Cefuroxime is often used to treat infections during pregnancy, but the timing of administration for surgical prophylaxis is being studied[1][2]
  • Newborns and infants: Research is ongoing to determine the best dosages and safety profile in this age group[6]
  • Obese patients: Studies are looking at how to adjust dosages based on body mass index (BMI)[7]
  • Patients with kidney problems: Dosage adjustments may be necessary for patients with impaired kidney function[5]
Your healthcare provider will consider these factors when prescribing cefuroxime.

Ongoing Research

Several clinical trials are currently underway to further our understanding of cefuroxime:

  • Comparing oral versus intravenous administration in pregnant women with kidney infections[4]
  • Studying the effects of cefuroxime on gut bacteria in newborns[2]
  • Investigating the best dosing strategies for preventing surgical site infections[5]
  • Examining how cefuroxime behaves in the bodies of infants after heart surgery[3]
These studies aim to improve the use of cefuroxime and enhance patient outcomes in various clinical scenarios.

Aspect Details
Main Uses Surgical prophylaxis, treatment of infections (e.g., pyelonephritis), antibiotic for infants and children
Administration Methods Intravenous (IV), oral, bolus doses, continuous infusion
Patient Populations Adults undergoing surgery, pregnant women, obese patients, newborns, infants, children
Key Study Areas Dosing strategies, timing of administration, effectiveness in different patient groups, pharmacokinetics in special populations
Potential Benefits Reduced post-surgical infections, effective treatment without hospitalization, appropriate dosing for various patient groups
Considerations BMI-based dosing, effects on newborn gut microbiota, use in patients with altered physiology (e.g., post-cardiac surgery)

FAQ

  • What is Cefuroxime Sodium used for in clinical trials? Cefuroxime Sodium is being studied for various uses, including preventing infections after surgery (especially colorectal and cardiac surgeries), treating pyelonephritis in pregnant women, and as an antibiotic for infants and children with infections.
  • How is Cefuroxime administered in these trials? The administration methods vary depending on the study. Some trials compare intravenous (IV) to oral administration, while others look at different dosing strategies such as bolus doses versus continuous infusion. The timing of administration (before or after surgical incision) is also being studied.
  • Are there any special considerations for Cefuroxime use in obese patients? Yes, one study is specifically looking at adjusting Cefuroxime dosage based on Body Mass Index (BMI). Patients with higher BMI may receive larger doses to ensure adequate antibiotic levels in their body.
  • How is Cefuroxime being studied in newborns and infants? Cefuroxime is being studied in newborns and infants to understand its pharmacokinetics (how the drug moves through the body), effectiveness, and safety in this vulnerable population. Researchers are measuring drug levels in blood and tissue to determine appropriate dosing.
  • What are some potential benefits of using Cefuroxime in clinical trials? Potential benefits include reducing post-surgical infections, treating pyelonephritis in pregnancy without requiring hospitalization, and providing effective antibiotic coverage for infants and children. Some trials are also exploring whether oral administration can be as effective as intravenous, which could reduce hospital stays and costs.

Ongoing Clinical Trials on Cefuroxime Sodium

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on How Antibiotics Work in the Spinal Fluid of Children with Brain Drains: Cefuroxime, Vancomycin, and Gentamicin with a Drug Combination

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria

Glossary

  • Cefuroxime Sodium: An antibiotic medication used to treat or prevent various bacterial infections. It belongs to the cephalosporin class of antibiotics.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Pyelonephritis: A type of urinary tract infection that affects one or both kidneys.
  • Surgical site infection: An infection that occurs after surgery in the part of the body where the surgery took place.
  • Body Mass Index (BMI): A measure that uses your height and weight to work out if your weight is healthy.
  • Antibiotic prophylaxis: The use of antibiotics to prevent infections, often given before surgery.
  • Cardiopulmonary bypass: A technique that temporarily takes over the function of the heart and lungs during surgery.
  • Gut microbiota: The community of microorganisms living in the digestive tracts of humans and other animals.
  • Endometritis: Inflammation of the inner lining of the uterus, usually due to infection.
  • Peritoneal dialysis: A treatment for kidney failure that uses the lining of your abdomen to filter your blood.

References

  1. https://clinicaltrials.gov/study/NCT01507974
  2. https://clinicaltrials.gov/study/NCT02072798
  3. https://clinicaltrials.gov/study/NCT02850250
  4. https://clinicaltrials.gov/study/NCT06527560
  5. https://clinicaltrials.gov/study/NCT05609240
  6. https://clinicaltrials.gov/study/NCT05388747
  7. https://clinicaltrials.gov/study/NCT03141476